Developer docs
API playgroundTry for free, no card

Search company profiles

Rijuven

Full company profile

uuid0009qm7

Namestring
Rijuven
Legal namestring
Rijuven Corp.
Websiteurl
rijuven.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Rijuven is a privately held medical device company founded in 2012 and headquartered in Pittsburgh, Pennsylvania, that builds connected point-of-care diagnostic platforms for cardiac and chronic care. The product portfolio centers on three hardware systems — CardioSleeve, a digital stethoscope attachment that records and analyzes synchronized ECG and heart sound data using Systolic Time Interval (STI) measurements; Rejiva EKG, a wireless, reusable chest-worn monitor that consolidates event, Holter, and Mobile Cardiac Outpatient Telemetry functionality; and Clinic in a Bag, a portable cloud-connected examination kit for facility-grade care in remote settings. These devices feed a cloud analytics platform that runs cardiac function algorithms, arrhythmia detection across 22 types, and a 4-zone traffic-light triage system, with interoperability exposed via ABDM-compliant FHIR R4 APIs in India.

Rijuven generates revenue through hardware sales of CardioSleeve and Rejiva devices bundled with recurring cloud software subscriptions and managed care extension services (telehealth, remote patient monitoring, self-exam kits, and home health) sold primarily via direct enterprise field sales to healthcare systems, hospitals, and clinical teams. Geographic coverage spans 8 countries — the United States, India, Kenya, South Africa, UAE, Saudi Arabia, Jordan, and Nepal — and the platform is positioned for primary care, post-acute/chronic care, and remote/underserved community deployments.

The company is led by co-founder Dr. Raj Kapoor (Pulmonary/Critical Care specialist) and Evens Augustin (Carnegie Mellon engineer, Pitt MBA), with operating leadership from Taras Silecky (prior Ascension Health Ventures and Western NIS Enterprise Fund experience). Cumulative disclosed funding through 2015 totaled roughly $3.78M across six rounds, and the most recent strategic emphasis has been on clinical validation (GGH Kurnool, n=373, April 2026) and ABDM integration in India to unlock national-scale procurement.

Short descriptiontext

Rijuven is a privately held medical device company founded in 2012 that builds connected point-of-care diagnostic platforms — CardioSleeve, Rejiva EKG, and Clinic in a Bag — with cloud analytics and telehealth, sold via direct enterprise sales to healthcare systems and hospitals across 8 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWexford, United States
HQ citystring
Wexford
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
connected medical devices, cardiac diagnostics, remote patient monitoring, digital auscultation, telehealth platform
Industry3 codes
PRIMARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Other Computer Related Services541519
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Connected Medical Devices / Point-of-Care Cardiac Diagnostics
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Connected Device Hardware Sales
TypeHardware Sales
Description

Rijuven generates revenue primarily through the sale of its connected medical device hardware (CardioSleeve, Rejiva Patch) bundled with cloud-based software subscriptions and analytics services. The platform supports recurring revenue from software licenses, monitoring services, and telehealth connectivity, alongside one-time hardware sales of examination platforms (Clinic in a Bag). Revenue streams span enterprise healthcare systems, hospital deployments, and care extension services.

rijuven.com
2Cloud Analytics & Software Platform
TypeSubscription Recurring
Description

Cloud-based software and analytics platform providing real-time data processing, STI cardiac analysis, arrhythmia detection, telehealth connectivity, and population health monitoring on a recurring subscription basis.

rijuven.com
3Care Extension & Remote Monitoring Services
TypeManaged Services
Description

Care extension services including remote patient monitoring, tele-health video portal, patient-facing apps, self-exam kits, and home health services bundled as managed services for healthcare providers, hospital discharge programs, and chronic care management.

rijuven.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1CardioSleeve
Description

Smart ECG stethoscope attachment that enables digital auscultation, EKG recording, and systolic time interval analysis for heart failure screening.

rijuven.com
+3 more records
Core offering1 text field

Rijuven develops and sells connected medical device platforms for cardiac diagnostics, remote patient monitoring, and chronic care management. Its core products include the CardioSleeve smart ECG stethoscope attachment, Rejiva EKG wireless cardiac monitoring patch, and Clinic in a Bag portable examination kit, all integrated with cloud-based analytics, telehealth connectivity, and the TeleFi care delivery model for healthcare systems, hospitals, and clinical teams.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • CardioSleeve achieved AUC of 0.942 (PEP parameter) for detecting HFrEF (EF < 40%) against echocardiographic gold standard in 373-patient prospective study at GGH Kurnool.
+5 more records
Product overview1 text field

Rijuven offers a connected healthcare platform with three core hardware products and integrated cloud software. CardioSleeve is a smart ECG stethoscope attachment for cardiac screening; Rejiva EKG is a wireless monitoring patch for continuous cardiac telemetry; Clinic in a Bag is a portable diagnostic kit enabling facility-grade examinations in any setting. The TeleFi Care Extension service ties these together with telemedicine connectivity, enabling providers to examine, monitor, and manage patients remotely across primary care, cardiac care, and chronic care settings.

Product and service4 records
1CardioSleeve
CategoryCardiac Diagnostic Device
Description

A smart ECG stethoscope attachment that records, analyzes, and displays synchronized ECG and heart sound acoustic data in real time. Enables early heart failure screening, arrhythmia detection, and murmur analysis using digital auscultation and systolic time interval (STI) measurements. Attaches to any existing stethoscope. Validated with AUC 0.942 for HFrEF detection.

2Rejiva EKG
3Clinic in a Bag
CategoryPortable Diagnostic Platform
Description

A comprehensive cloud-based examination platform combining diagnostic devices, lab work, and integrated telemedicine. Enables clinical teams to wirelessly deploy facility-grade care to patients at any point of care including remote communities, nursing homes, and patient homes. Supports offline mode for deployment in care deserts. Includes AI-powered health data analysis.

4Care Extension (TeleFi)
CategoryCare Delivery Service
Description

A care delivery model combining telemedicine with in-clinic care, home-based care, and remote patient monitoring. Extends healthcare access by connecting providers to patients through video conference, patient-facing applications, self-exam kits, telehealth connectivity, and home health services. Enables care teams to examine, monitor, and manage patients at any location.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1Government General Hospital (GGH) Kurnool, Andhra Pradesh
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-01
Description

Prospective observational clinical validation study of Rijuven CardioSleeve STI measurements in 373 patients against echocardiographic assessment for HFrEF detection. Conducted as part of Andhra Pradesh Medtech Hackathon 2026. Study supersedes earlier 259-patient interim analysis. All patients underwent simultaneous CardioSleeve STI measurement and echocardiographic assessment.

rijuven.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-01-01
Description

CardioSleeve integrates with India's national digital health infrastructure (ABDM). Supports ABHA patient identity (14-digit health ID), HIE-CM consent-based data sharing, FHIR R4 APIs, SNOMED CT clinical terminology, LOINC observation codes, and UHI service discovery. Device must be registered in the NHA Medical Device Registry prior to production deployment in ABDM-connected HMIS.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Multi-institutional collaborative event co-hosting the CardioSleeve Clinical Validation Dashboard presentation. Brought together GGH Kurnool, Rijuven, and Andhra Pradesh health system stakeholders for prospective observational validation of CardioSleeve STI measurements against echocardiographic gold standard.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Prior clinical validation study (2019, n=258, Indian mixed cardiology population) for STI-based cardiac function assessment. Achieved 98.79% specificity and 70% sensitivity. Results confirmed and cross-validated by Rijuven's CardioSleeve validation dashboard against current 373-patient GGH Kurnool study.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AliveCor produces KardiaMobile personal ECG devices and enterprise KardiaComplete remote cardiac monitoring services — directly comparable to Rijuven's Rejiva EKG patch in the connected ambulatory cardiac monitoring category.

TypeBroad incumbent
Description

GE Healthcare offers enterprise patient monitoring and ECG systems across hospital systems globally — a broad incumbent whose installed hospital base competes with Rijuven's hospital channel opportunities.

TypeDirect peer
Description

Eko Health manufactures AI-powered digital stethoscopes (CORE 500) with FDA-cleared cardiac and pulmonary disease detection algorithms — the most direct competitor to Rijuven's CardioSleeve in digital auscultation for primary care and cardiology.

TypeDirect peer
Description

iRhythm's Zio long-term continuous cardiac monitoring patch and associated cloud analytics platform compete with Rijuven's Rejiva patch in ambulatory cardiac telemetry and arrhythmia detection.

TypeBroad incumbent
Description

Omron Healthcare manufactures connected blood pressure monitors, ECG devices, and vital signs wearables — a broader incumbent in the connected home cardiac and vital signs monitoring category overlapping with Rejiva.

TypeEmerging player
Description

HeartSciences develops AI-ECG algorithms for earlier detection of heart disease using standard 12-lead ECG hardware — an emerging player in the same AI-enhanced cardiac screening category as CardioSleeve.

TypeEmerging player
Description

Sanolla is an emerging digital auscultation company developing AI-powered smart stethoscope technology for primary care — explicitly named as a Rijuven competitor in the digital auscultation market.

TypeRegional player
Description

HealthArc and similar India-focused RPM platforms represent regional players with overlapping telehealth and remote monitoring offerings in the Indian market where Rijuven has built its strongest ABDM integration footprint.

TypeBroad incumbent
Description

Philips acquired BioTelemetry to build a leading remote cardiac monitoring franchise — provides broad enterprise RPM services overlapping with Rijuven's Rejiva monitoring and TeleFi care extension model.

TypeBroad incumbent
Description

3M Littmann CORE digital stethoscope with Eko electronic core represents the established incumbent in digital auscultation — competes with CardioSleeve through a different attach model (integrated vs. accessory).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rijuven

Connected Medical Devices / Point-of-Care Cardiac Diagnosticsrijuven.com

Rijuven is a privately held medical device company founded in 2012 that builds connected point-of-care diagnostic platforms — CardioSleeve, Rejiva EKG, and Clinic in a Bag — with cloud analytics and telehealth, sold via direct enterprise sales to healthcare systems and hospitals across 8 countries.

What Rijuven does

Rijuven is a privately held medical device company founded in 2012 and headquartered in Pittsburgh, Pennsylvania, that builds connected point-of-care diagnostic platforms for cardiac and chronic care. The product portfolio centers on three hardware systems — CardioSleeve, a digital stethoscope attachment that records and analyzes synchronized ECG and heart sound data using Systolic Time Interval (STI) measurements; Rejiva EKG, a wireless, reusable chest-worn monitor that consolidates event, Holter, and Mobile Cardiac Outpatient Telemetry functionality; and Clinic in a Bag, a portable cloud-connected examination kit for facility-grade care in remote settings. These devices feed a cloud analytics platform that runs cardiac function algorithms, arrhythmia detection across 22 types, and a 4-zone traffic-light triage system, with interoperability exposed via ABDM-compliant FHIR R4 APIs in India.

Rijuven generates revenue through hardware sales of CardioSleeve and Rejiva devices bundled with recurring cloud software subscriptions and managed care extension services (telehealth, remote patient monitoring, self-exam kits, and home health) sold primarily via direct enterprise field sales to healthcare systems, hospitals, and clinical teams. Geographic coverage spans 8 countries — the United States, India, Kenya, South Africa, UAE, Saudi Arabia, Jordan, and Nepal — and the platform is positioned for primary care, post-acute/chronic care, and remote/underserved community deployments.

The company is led by co-founder Dr. Raj Kapoor (Pulmonary/Critical Care specialist) and Evens Augustin (Carnegie Mellon engineer, Pitt MBA), with operating leadership from Taras Silecky (prior Ascension Health Ventures and Western NIS Enterprise Fund experience). Cumulative disclosed funding through 2015 totaled roughly $3.78M across six rounds, and the most recent strategic emphasis has been on clinical validation (GGH Kurnool, n=373, April 2026) and ABDM integration in India to unlock national-scale procurement.

Rijuven firmographics

Firmographics
Name
Rijuven
Legal name
Rijuven Corp.
Website
https://rijuven.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
1–10 employees
Short description
Rijuven is a privately held medical device company founded in 2012 that builds connected point-of-care diagnostic platforms — CardioSleeve, Rejiva EKG, and Clinic in a Bag — with cloud analytics and telehealth, sold via direct enterprise sales to healthcare systems and hospitals across 8 countries.
Ownership category
akta.pro rank

Rijuven industry classification

Industry
Product category
Connected Medical Devices / Point-of-Care Cardiac Diagnostics
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Other Computer Related Services (541519)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Connected medical devices
  • Cardiac diagnostics
  • Remote patient monitoring
  • Digital auscultation
  • Telehealth platform

Where Rijuven is headquartered

Location

Headquarters

HQ city
Wexford
HQ country
United States
HQ region
North America

Offices8 records

Markets served

Rijuven business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Connected Device Hardware Sales: Rijuven generates revenue primarily through the sale of its connected medical device hardware (CardioSleeve, Rejiva Patch) bundled with cloud-based software subscriptions and analytics services. The platform supports recurring revenue from software licenses, monitoring services, and telehealth connectivity, alongside one-time hardware sales of examination platforms (Clinic in a Bag). Revenue streams span enterprise healthcare systems, hospital deployments, and care extension services.
  2. Cloud Analytics & Software Platform: Cloud-based software and analytics platform providing real-time data processing, STI cardiac analysis, arrhythmia detection, telehealth connectivity, and population health monitoring on a recurring subscription basis.
  3. Care Extension & Remote Monitoring Services: Care extension services including remote patient monitoring, tele-health video portal, patient-facing apps, self-exam kits, and home health services bundled as managed services for healthcare providers, hospital discharge programs, and chronic care management.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Rijuven product offering

Product offering

Core offering

Rijuven develops and sells connected medical device platforms for cardiac diagnostics, remote patient monitoring, and chronic care management. Its core products include the CardioSleeve smart ECG stethoscope attachment, Rejiva EKG wireless cardiac monitoring patch, and Clinic in a Bag portable examination kit, all integrated with cloud-based analytics, telehealth connectivity, and the TeleFi care delivery model for healthcare systems, hospitals, and clinical teams.

Product overview

Rijuven offers a connected healthcare platform with three core hardware products and integrated cloud software. CardioSleeve is a smart ECG stethoscope attachment for cardiac screening; Rejiva EKG is a wireless monitoring patch for continuous cardiac telemetry; Clinic in a Bag is a portable diagnostic kit enabling facility-grade examinations in any setting. The TeleFi Care Extension service ties these together with telemedicine connectivity, enabling providers to examine, monitor, and manage patients remotely across primary care, cardiac care, and chronic care settings.

Differentiator

Problem solved

Functional benefit

Brands

  • CardioSleeve: Smart ECG stethoscope attachment that enables digital auscultation, EKG recording, and systolic time interval analysis for heart failure screening.
  • Rejiva
  • Clinic in a Bag
  • TeleFi

Products and services

  • CardioSleeve A smart ECG stethoscope attachment that records, analyzes, and displays synchronized ECG and heart sound acoustic data in real time. Enables early heart failure screening, arrhythmia detection, and murmur analysis using digital auscultation and systolic time interval (STI) measurements. Attaches to any existing stethoscope. Validated with AUC 0.942 for HFrEF detection.
  • Rejiva EKG
  • Clinic in a Bag A comprehensive cloud-based examination platform combining diagnostic devices, lab work, and integrated telemedicine. Enables clinical teams to wirelessly deploy facility-grade care to patients at any point of care including remote communities, nursing homes, and patient homes. Supports offline mode for deployment in care deserts. Includes AI-powered health data analysis.
  • Care Extension (TeleFi) A care delivery model combining telemedicine with in-clinic care, home-based care, and remote patient monitoring. Extends healthcare access by connecting providers to patients through video conference, patient-facing applications, self-exam kits, telehealth connectivity, and home health services. Enables care teams to examine, monitor, and manage patients at any location.

Quantifiable outcome

  • CardioSleeve achieved AUC of 0.942 (PEP parameter) for detecting HFrEF (EF < 40%) against echocardiographic gold standard in 373-patient prospective study at GGH Kurnool.
  • +5 more outcomes

Companies that use Rijuven

Customer profile

Named customers2 records

Segments6 records

Ideal customer profiles5 records

Rijuven technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability7 records

Feature7 records

Rijuven partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • Government General Hospital (GGH) Kurnool, Andhra PradeshcoreStrategic or Co-development Partner · 1 April 2026Prospective observational clinical validation study of Rijuven CardioSleeve STI measurements in 373 patients against echocardiographic assessment for HFrEF detection. Conducted as part of Andhra Pradesh Medtech Hackathon 2026. Study supersedes earlier 259-patient interim analysis. All patients underwent simultaneous CardioSleeve STI measurement and echocardiographic assessment.
  • National Health Authority (NHA) — Ayushman Bharat Digital Mission (ABDM)coreTechnology or Integration · 1 January 2026CardioSleeve integrates with India's national digital health infrastructure (ABDM). Supports ABHA patient identity (14-digit health ID), HIE-CM consent-based data sharing, FHIR R4 APIs, SNOMED CT clinical terminology, LOINC observation codes, and UHI service discovery. Device must be registered in the NHA Medical Device Registry prior to production deployment in ABDM-connected HMIS.
  • Andhra Pradesh Medtech Hackathon 2026coreStrategic or Co-development Partner · 1 January 2026Multi-institutional collaborative event co-hosting the CardioSleeve Clinical Validation Dashboard presentation. Brought together GGH Kurnool, Rijuven, and Andhra Pradesh health system stakeholders for prospective observational validation of CardioSleeve STI measurements against echocardiographic gold standard.
  • Ramesh Hospitals, IndiacoreStrategic or Co-development Partner · 1 January 2019Prior clinical validation study (2019, n=258, Indian mixed cardiology population) for STI-based cardiac function assessment. Achieved 98.79% specificity and 70% sensitivity. Results confirmed and cross-validated by Rijuven's CardioSleeve validation dashboard against current 373-patient GGH Kurnool study.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Rijuven competitors and assessment

Company assessment

Direct peers

  • AliveCor: AliveCor produces KardiaMobile personal ECG devices and enterprise KardiaComplete remote cardiac monitoring services — directly comparable to Rijuven's Rejiva EKG patch in the connected ambulatory cardiac monitoring category.
  • Eko Health: Eko Health manufactures AI-powered digital stethoscopes (CORE 500) with FDA-cleared cardiac and pulmonary disease detection algorithms — the most direct competitor to Rijuven's CardioSleeve in digital auscultation for primary care and cardiology.
  • iRhythm Technologies: iRhythm's Zio long-term continuous cardiac monitoring patch and associated cloud analytics platform compete with Rijuven's Rejiva patch in ambulatory cardiac telemetry and arrhythmia detection.

Broad incumbents

  • GE Healthcare: GE Healthcare offers enterprise patient monitoring and ECG systems across hospital systems globally — a broad incumbent whose installed hospital base competes with Rijuven's hospital channel opportunities.
  • Omron Healthcare: Omron Healthcare manufactures connected blood pressure monitors, ECG devices, and vital signs wearables — a broader incumbent in the connected home cardiac and vital signs monitoring category overlapping with Rejiva.
  • Philips (RPM / BioTelemetry): Philips acquired BioTelemetry to build a leading remote cardiac monitoring franchise — provides broad enterprise RPM services overlapping with Rijuven's Rejiva monitoring and TeleFi care extension model.
  • 3M (Littmann CORE): 3M Littmann CORE digital stethoscope with Eko electronic core represents the established incumbent in digital auscultation — competes with CardioSleeve through a different attach model (integrated vs. accessory).

Emerging players

  • HeartSciences: HeartSciences develops AI-ECG algorithms for earlier detection of heart disease using standard 12-lead ECG hardware — an emerging player in the same AI-enhanced cardiac screening category as CardioSleeve.
  • Sanolla: Sanolla is an emerging digital auscultation company developing AI-powered smart stethoscope technology for primary care — explicitly named as a Rijuven competitor in the digital auscultation market.

Regional players

  • Hippocratic AI / HealthArc: HealthArc and similar India-focused RPM platforms represent regional players with overlapping telehealth and remote monitoring offerings in the Indian market where Rijuven has built its strongest ABDM integration footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Rijuven social profiles

Digital presence

Rijuven compliance and trust

Trust signal

Compliance1 record

Rijuven financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rijuven leadership team

Management profile

Number of profiles

Profiles4 records

Rijuven funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rijuven M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rijuven

What does Rijuven do?

Rijuven develops and sells connected medical device platforms for cardiac diagnostics, remote patient monitoring, and chronic care management. Its core products include the CardioSleeve smart ECG stethoscope attachment, Rejiva EKG wireless cardiac monitoring patch, and Clinic in a Bag portable examination kit, all integrated with cloud-based analytics, telehealth connectivity, and the TeleFi care delivery model for healthcare systems, hospitals, and clinical teams.

Is Rijuven a public or private company?

Rijuven is a private company. It is classified as venture growth investor backed and is currently operating.

When was Rijuven founded?

Rijuven was founded in 2012. It employs 1 to 10 people.

Where is Rijuven based?

Rijuven is headquartered in Wexford, United States, in the North America region.

How does Rijuven make money?

Three revenue lines are on record. Connected Device Hardware Sales are the primary driver. The others are cloud Analytics & Software Platform and care Extension & Remote Monitoring Services.

Who are Rijuven's main competitors?

Direct peers on record are AliveCor, Eko Health and iRhythm Technologies. Broad incumbents are GE Healthcare, Omron Healthcare, Philips (RPM / BioTelemetry) and 3M (Littmann CORE). Emerging players are HeartSciences and Sanolla. Hippocratic AI / HealthArc is listed as a regional player.

Does Rijuven have an API?

Yes. Rijuven offers ABDM (Ayushman Bharat Digital Mission) compliant REST APIs for healthcare data interoperability. The APIs support patient registration via ABHA (Ayushman Bharat Health Account), FHIR R4 observation submission for CardioSleeve STI measurements, HIE-CM consent-based data sharing, unified health interface discovery, and HMIS/EHR integration. Authentication uses OAuth 2.0 Bearer tokens. API endpoints include: POST /v1/abdm/patients/register (ABHA registration), POST /v1/fhir/r4/Observation (STI measurement submission), GET /v1/fhir/r4/Observation (historical data retrieval), POST /v1/fhir/r4/DiagnosticReport (diagnostic report submission), POST /v0.5/consent-requests/init (HIE-CM consent requests), GET /api/uhi/v0/search (UHI service discovery). Data standards: HL7 FHIR R4, SNOMED CT, LOINC (59010-6 for PEP, 59408-2 for MPI/Tei Index). Implementation requires OAuth 2.0 Bearer token authentication via ABDM Gateway. Developer documentation is at www.rijuven.com.

What industry is Rijuven in?

Rijuven's product category is Connected Medical Devices / Point-of-Care Cardiac Diagnostics. Its primary akta.pro industry code is HLACAPAK, Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireHenry Schein Medical Announces Exclusive Distribution Agreement For Rijuven's CardioSleeveHenry Schein Medical announced an exclusive distribution agreement with Rijuven to sell the CardioSleeve diagnostic device, a stethoscope attachment that records synchronized electrocardiogram and heart sound signals and transmits real-time data to smartphones or tablets via Bluetooth. The device offers cloud-based analysis to help physicians diagnose heart conditions including 22 types of arrhythmias, heart failure, and murmur pathology, either in clinical settings or remotely. The announcement, made during American Heart Month, expands Henry Schein Medical's portfolio of cardiovascular health solutions.PrwebRijuven Releases ‘Clinic in a Bag’ – The power of a clinic deployed to any patient, at any time, in any location.Rijuven launched Clinic in a Bag, a mobile examination platform combining connected devices with cloud analysis and telemedicine. It adds vitals, blood glucose, lipid panel, urinalysis, and ultrasound to its CardioSleeve, and is used by providers in India, the Middle East, South Africa, and the U.S. The platform aims to keep patients out of hospitals.MedCity NewsWow of the Week: Stethoscope gets some cool design innovationsRijuven Corp received FDA 510(k) clearance for the CardioSleeve, a stethoscope accessory that records and analyzes heart sounds in real time. The device is intended for clinicians and is expected to launch in the fourth quarter. A separate optical stethoscope design concept displays waveform and vitals on a knob.